Main Menu
Menu
Main Menu

BioCreate Program

by

BioCreate program banner showing the Canada and Ontario Genomics logo

Ontario Genomics’ BioCreate program is open to small- and medium-sized enterprises (SMEs) in southern Ontario seeking to commercialize genomics and engineering biology enabled products and/or technologies in the health, food and agriculture, and cleantech sectors at a Technology Readiness Level (TRL) of 4+. BioCreate will provide funding, access to mentorship and business support to enable companies to raise additional financing to achieve commercial outcomes.

The multi-phase BioCreate program will include direct, non-repayable funding of $150,000 that will be matched by an additional $100,000 (minimum) from participating companies to a total project size of $250,000 or more. Funded companies will have access to 18-months of intensive business mentorship and access to critical infrastructure provided by Ontario Genomics’ (OG’s) strategic sectoral and regional partnerships. Each cohort will conclude with an investor showcase, giving the companies an opportunity to pitch to investors and potential partners. BioCreate will support up to 32 high-potential companies over five years with seven total cohorts (rolling intake with funding decisions twice per year).

Biocreate header with three phases

The BioCreate program consists of three phases:

The BioCreate expert panel will evaluate market potential and technical feasibility of eligible applications, based on the evaluation criteria defined in the Program Guide. Successful applicants will receive up to $150,000 in non-repayable funding and must contribute $100,000 minimum to leverage the funding for their 18-month project. The application process consists of three stages:

  • Expression of interest
  • Invitation to submit application/submission of written application
  • Pitch to BioCreate Expert Panel

During the course of the funded project, the BioCreate program will support technology and business development to successful applicants through business mentors, patent expertise, regulatory support, and other support as defined by the needs of the company. Access to infrastructure can be facilitated through our program partners depending on company needs and location. OG’s strategic sectoral and regional partnerships include Velocity (Waterloo), Synapse Life Sciences Consortium (Hamilton), Toronto Metropolitan University SDZ (Toronto) and Cleantech Commons (Peterborough). SMEs will also work with one or more BioCreate partners and Ontario Genomics BioCreate team to develop a pitch deck to present at the Investor Showcase in Phase III.

After the successful completion of the 18-month program, teams will participate in an investor showcase where they will pitch to an audience of regional enablers and investors in efforts to receive follow-on investment.

Application Steps and Dates

Interested SMEs should submit a BioCreate intake form at any time. A representative from the BioCreate team will reach out to you to discuss your project idea. Eligible applicants will be invited to submit an application.

For more information on the BioCreate program including eligibility requirements and evaluation criteria see the Program Guide. If you have questions, please contact BioCreate.

As a signatory to the 50-30 Challenge, Inclusivity, Diversity, Equity and Accessibility (IDEA) is a core component of Ontario Genomics’ ethos, including within this program. Furthermore, Ontario’s population is highly diverse, and effective and authentic diversity and inclusion strategies are essential for southern Ontario organizations to thrive and achieve their goals. We encourage applications from diverse teams and all equity-deserving groups.

The BioCreate program is supported by the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) and by Ontario Genomics. The current budget is greater than $7 million over five years.

Ontario Genomics-CANSSI Ontario Postdoctoral Fellowship in Genome Data Science

by

We are pleased to open the Request for Applications (RFA) for the Ontario Genomics and CANSSI Ontario Postdoctoral Fellowship, establishing another joint Postdoctoral Fellowship in Genome Data Science.

This Fellowship will support the work of early-career investigators pursuing research in the areas of statistical genetics, environmental genetics, or the economics and impacts of genomic technologies, in a climate-changing world.

The Fellowship offers two-year salary support for up to $50,000 per year for postdoctoral fellows undertaking full-time research at a CANSSI Ontario partner university or their affiliated research institutes. Candidates are responsible for selecting, contacting, and securing the commitment of two faculty members to jointly supervise them in their project, one being a statistical geneticist, genetic epidemiologist, or environmental epidemiologist.

Research projects of particular interest are those that:

  • Bridge data from the lab into the real world (commercial or governmental applications);
  • Develop tools and link datasets in meaningful ways for policy development and implementation; and
  • Establish frameworks and methods that allow consistent comparison of results, and that give an understanding of the limitations and opportunities.

Examples include:

  • Methods and tools to address climate change, food systems, and sustainability.
  • Methods and tools to address biodiversity, reflecting localized data and values.
  • Life cycle inventory and analysis of data that can be used to support the circular bioeconomy.
  • Robust methods that incorporate the diversity of populations and data.

Applicant Eligibility

Research Project Eligibility

  • Research projects that focus on statistical methodology and tool development, including computational tools, may be considered. We encourage applications from candidates combining ’omics data with other data to overcome challenges, especially as it applies to the environment and climate change. Final selection is at the discretion of the adjudication panel.
  • Funding eligibility of submissions will be assessed based on defined eligibility criteria related to scientific excellence and innovation by a joint adjudication panel.

Funding and Tenure

    • Funding Availability: Up to two years.
    • Maximum Fellowship Value: $50,000 per year for up to $100,000 over two years.

    We expect to fund the highest-ranked candidates.

Landing Pad Investment Program (LPIP)

by

This competition is closed. All submitted proposals will be assessed according to the process outlined in the competition timeline, and results will be announced as indicated.

Call for genomics or engineering biology start-ups solving global challenges in therapeutics, future of food, biomaterials, biological tools, diagnostics and bioinformatics/AI-based technologies

The Ontario Genomics (OG) Landing Pad Investment Program (LPIP) seeks to provide investment and support to help Ontario-based genomics and engineering biology1 companies to start and scale successfully. To enable this, OG is offering support to start-ups that attend an approved International Accelerator Program and return to Ontario upon completion. The Landing Pad Investment Program partner IndieBio (San Francisco & New York), offers a minimum of $275,000 USD upon acceptance to their program, and is backed by the global venture capital firm SOSV.

  • Successful applicants will receive a $100,000 investment from Ontario Genomics
  • Companies will benefit from mentorship which may include: regulatory pathway assistance, global outlook and connections, understanding of export markets, business model strategy, technical development, funding and foreign investment.
  • Companies can be connected to Ontario’s leading incubators and support organizations such as Velocity, Synapse, McMaster Innovation Park and Ryerson’s SDZ.

How it works:

Icon of a lightbulb with text below: "Contact OGif your genomics or engineering biology start-up has potential for large impact. Key icon: Attend an international Accelerator Program to qualify for the LPIP. Rocket Icon: Apply for LPIP for investment, connections to lab space and mentorship

*Impacting at least 1B people or is part of a $1B market

Get Started

  • Step 1: Contact Britney Hess, Ontario Genomics Manager, Investment and Venture Development, if you have any questions about the program or your eligibility!
  • Step 2: Fill in the application form (linked above) and send it to Britney Hess by December 1, 2021.
  • Step 3: Eligible top-ranked applicants will pitch to an expert panel on December 15, 2021. Top-ranked applicants will undergo a due diligence process.
  • Step 4: Successful applicants will receive $100,000 in investment from Ontario Genomics, as well as opportunities for mentorship and connections to lab space.

1.Genomics can encompass proteomics, transcriptomics, epigenomics, bioinformatics and other related disciplines that involve systematic, comprehensive and high-throughput procedures to study cellular constituents and function. Engineering (or synthetic) biology is a convergence of genomics and molecular biosciences with computing, automation, miniaturization, artificial intelligence (AI), and the application of engineering principles to biological systems. See OG Engineering Biology Whitepaper for examples

Industry Challenge 2020 Program (CLOSED)

by

This competition is closed. All submitted proposals will be assessed according to the process outlined in the competition timeline, and results will be announced as indicated.

Industry challenge program banner, a man standing with his hands on his hips and looking at a whiteboard that has DNA drawn on it
Healthy Lives, Healthy Economy, Healthy Planet through Genomics

Open Call for Challenges

Purpose

With the Industry Challenge Program, Ontario Genomics will provide teams with funding for novel and innovative projects to solve pressing challenges and address industry opportunities through the application of genomics-based solutions across key sectors of the Ontario economy with the intent to drive economic growth, improve quality of life and Ontario’s global leadership.

Ontario Genomics is issuing an “Open Call for Challenges” for genomics and engineering biology innovators to solve industry and other end-user identified challenges within and across agriculture and agri-food, human health, industrial biotechnology and natural resources and the environment in one or more of the five areas identified below.

  • Sustainable Food and Biomaterials Production
  • Rapid Genomic Diagnostics in Healthcare, Food Safety & Agriculture, and the Environment
  • Biomanufacturing and Scale Up from the Lab to the Factory
  • Roadmaps for Reducing Red Tape, Regulatory Burden or other Barriers
  • New Paradigms for Rare Disease Treatment

The Industry Challenge 2020 Program intends to catalyze and support collaboration in the application of genomics and engineering biology solutions to solve challenges identified by industry. This “industry-pull” approach is designed to enable market-informed outcomes and maximize the impact of these projects. This program is open to creative partnerships and collaborative teams (e.g. teams comprising industry, industry-academia, industry-industry, industry-other) that are in the position to address the identified challenge or opportunity and implement the results from the project.

Project outcomes should enable the applicant to implement the next steps, e.g. follow-on investment, increase technology readiness through next level applied research, validate a new business opportunity, obtain future partners etc. It is expected that the knowledge generated will have a high potential for future implementation by the industry, resulting in a marketable or translatable asset and will ultimately create social and/or economic benefit for Ontario, including the creation of jobs.

Funding

Ontario Genomics will provide up to twelve (12) individual awards of $25,000 each for teams to be used for short duration (up to 12 months) research projects. Each project must be matched with a minimum of $25,000 contribution from the industry (cash and in-kind acceptable), to a total project size of $50,000 or more. Higher funding could be requested in exceptional cases and would have to be matched dollar for dollar by the industry partner. Applicants must ensure that the research funded through the Industry Challenge Program is independent of current funding or is incremental to previously funded projects.

Eligibility

To be eligible for Industry Challenge 2020, a proposal must conform to the following criteria:

  • The proposal must respond to the objectives and intent of the Industry Challenge 2020 program (as described above)
  • The project must address an industry-identified challenge within one or more of the five areas identified above that can be solved with a genomics or engineering biology solution
  • The team must comprise of an Ontario-based industry or other industry partnerships (as described above)
  • If the industry is a company, the company must be incorporated prior to the application date
  • Funded research must be performed in Ontario, and awarded funds will not flow outside of Ontario
  • Ontario Genomics funds must flow to the industry team member. In exceptional cases, it may go to another team member and only if agreed upon by all parties
  • Co-funding is required from the industry, at a minimum of $25,000 (cash and in-kind acceptable)
  • Project duration should not exceed one year in length unless agreed upon by all parties

How to Apply

The Industry Challenge Competition will consist of a three-stage gated application process:

  • Intent to Apply (screening calls with Ontario Genomics, see below)
  • Submission of Written Application and
  • Pitch to Expert Panel.

Potential applicants must contact Elaine Corbett, Director of Strategic Partnerships to discuss their project idea. Ontario Genomics will help determine eligibility, positioning of the project and will provide an invitation to apply for eligible applicants.

Ontario Regional Priorities Partnership Program (ON-RP3) (CLOSED)

by

This competition is closed. All submitted proposals will be assessed according to the process outlined in the competition timeline, and results will be announced as indicated.

Ontario regional priorities partnership program (ON-RP3)

Rapid advances in genomics research and their application within Ontario’s diverse agriculture and agri-food sector have the potential to dramatically impact and improve both Ontario’s economy and the well-being of its people. Genomics, which to date has been applied primarily in major field crops and select livestock species, offers tremendous untapped potential to enhance the productivity, sustainability and profitability of many more segments of this sector. Ontario is well-known for its extensive research community and robust private sector, which have led to highly successful industry-academic partnerships. Through partnerships like these, Ontario is uniquely positioned to lead the application of genomics/genomics-derived technologies, tools and processes to advance the agriculture and agri-food sector.

To this end, Ontario Genomics (OG) has partnered with Agricultural Adaptation Council (AAC) and Genome Canada (GC) to deliver the new Ontario Regional Priorities Partnership Program (ON-RP3). Funding through this program will support co-led industry-academic, proof-of-concept stage projects within Ontario’s agriculture and agri-food sector. These projects will deliver genomics-derived technologies, tools and processes for industry-identified challenges and opportunities. The outcomes of these projects will position teams for successful implementation within two years or less of project completion.

Objectives

The primary objectives of the ON-RP3 are to:

  • Develop industry-academic partnerships that will drive the adoption of genomics-derived technologies, tools and processes to advance the Ontario agriculture and agri-food sector
  • Address industry-identified challenges and/or opportunities in the agriculture and agri-food sector and demonstrate the readiness of genomics solutions for implementation
  • Achieve the benefits of genomic discoveries by bridging the gap between applied research and implementation

Key Parameters of the Program

The ON-RP3 program is open to Ontario-based, co-led industry-academic projects. Industry includes for-profit companies and not-for-profit organizations actively operating in the Ontario agriculture and agri-food sector. Proposed projects must address real-world challenges and/or opportunities in Ontario’s agriculture and agri-food sector by using genomics/genomics-derived solutions.

  • Eligible Projects: Proof-of-concept stage projects with a clear plan for implementation within two years or less of project completion.
  • Eligible Applicants: Projects must be co-led by an Industry Lead and an Academic Lead, both based in Ontario.
  • Funding Available: Up to $2 million.
  • Project Size: $375,000 – $500,000 total project budget; smaller projects of at least $150,000 will be considered if they are well-justified and still meet the review criteria.
  • Co-funding: 1/3 of the total project budget must be obtained from eligible sources including the Industry Lead. A minimum of 1/6 of the total project budget must be in the form of cash obtained from the Industry Lead.
  • Funding Duration: One to three years, beginning no earlier than July 1, 2019 and ending no later than June 30, 2022.
  • Communications Plan: Projects must present a strong plan to communicate the project outcomes to a broad audience.

ON-RP3 Public Education and Engagement Initiative: Successful project teams that are selected for funding will be required to work collaboratively with OG, AAC and GC on a common, group-identified public education/engagement-themed initiative. The aim will be to identify and implement an initiative that benefits all projects. This initiative is expected to begin in the summer of 2020 and will be financially supported by OG, AAC and GC.

Eligibility

To be considered eligible, projects must:

  1. Respond to the objectives and intent of the ON-RP3 program
  2. Have an eligible Industry Lead and Academic Lead located in Ontario and demonstrate that the project being funded will be performed in, and benefit Ontario
  3. Put forward a genomics or genomics-derived solution (technologies, tools and processes) for an agriculture and agri-food sector-driven challenge or opportunity
  4. Align within one or more of the outlined strategic priorities listed below
  5. Build on existing research/preliminary data to demonstrate proof-of-concept by the end of the funding period
  6. Provide a plan that demonstrates how implementation will be achieved within two years or less of project completion
  7. Provide a communications plan

Proof-of-concept stage projects are defined as projects that build on existing discovery research and/or preliminary data towards Research & Development (R&D) that demonstrates the feasibility of implementing the genomics/genomics-derived solution. With the proof-of-concept data generated by end of the project, teams should be well-positioned to execute their defined implementation plan.

Discovery research with a seed sprouting icon, proof of concept with a growing sapling icon, implementation with a tree icon

Strategic Priorities

Projects must align with one or more of the strategic priorities outlined below, that are  based on the recommendations from the sector strategy report, Genomics for Agriculture & Agri-Food: Ontario’s Strategic Opportunity.  This report was prepared by Ontario Genomics following extensive sector review and consultations with academic, government, industry and other sector stakeholders:

  • Multidisciplinary Research – Augment multidisciplinary R&D using a systems biology approach, with a focus on increased understanding of microbiomes and their interconnectivity to human health
  • Sustainable Agriculture & Food – Prioritize programs for sustainable agriculture and food that consider the economy, the environment, and society, for crop production and livestock
  • Advanced Processing Systems – Enhance advanced manufacturing and processing systems for both food and industrial bioproducts, including fermentation and traceability
  • Rapid Diagnostics & Biologics – Develop rapid diagnostic methods to support regulation and trade, rapid disease detection and traceability in crops and livestock, and biologics to reduce the use of antimicrobials
  • Address Barriers to Adoption – Address barriers to the adoption of genomics innovations including issues related to data sharing, intellectual property, regulation and public acceptance
  • Leverage Computational Biology & Artificial Intelligence – Leverage Ontario’s strengths in computational biology and artificial intelligence to accelerate the development and application of agricultural genomics-based innovations

Application Review Process

The ON-RP3 application process includes three stages, as follows:

  1. Registration (Eligibility Assessment)
  2. Application Submission
  3. Application Review

Pre-commercial Business Development Fund (PBDF) (CLOSED)

by

This competition is closed. All submitted proposals will be assessed according to the process outlined in the competition timeline, and results will be announced as indicated.

PBDF Pre-commercial business development fund, ontario genomics banner. there is a blue lightbulb that is lit up in the left-hand corner

Ontario Genomics, through its Pre-commercial Business Development Fund (PBDF), is a committed investment partner supporting late-stage academic research and early-stage companies developing promising “’omics [1]” and ’omics-enabled technologies.

The PBDF is an investment fund uniquely focused on enabling the advancement of Ontario ’omics research projects and technology development toward commercialization and economic impact. Specifically, it aims to provide early-stage financial support as companies (with or without academic collaborators) move towards commercial applications, to speed up the transfer of products from R&D to market.

The Partnership

The fund invests up to C$100,000 per project. Our partnership with recipients includes not only financing, but also mentorship and guidance during the programs’ execution phase and thereafter based on our strong understanding of ’omics technologies and their potential commercial applications. Previous recipients of PBDF funding have included Ontario universities, research institutes and start-up companies.

Our Objectives

  • Create downstream economic benefits from ’omics research;
  • Support scientific entrepreneurs and start-ups; and
  • Generate returns for future PBDF investments.

Areas of Interest

Broad areas of interest for the PBDF include (but are not restricted to):

  • Biofuels, bioproducts
  • Human or animal diagnostics
  • Human or animal therapeutics
  • Crop or livestock trait improvements
  • Environmental management (related to water, mining, energy, other)
  • Forestry, natural resources
  • Laboratory and medical devices
  • Food, nutrition
  • Informatics including databases, software, other tools

Funding Criteria

We look for promising projects or opportunities that:

  • Leverage ’omics and associated technologies, and
  • Fall in the proof-of-principle (validation) phase of research.

We look for a balance of best-in-class, innovative science and high commercial potential.

The PBDF ranks opportunities in terms of the extent to which they meet the following criteria:

  • The investment would increase the likelihood of a near-term (i.e. within 24 months), ‘next-step’ event by offering concrete, definitive milestone(s) and uniquely enables rapid progress towards the marketplace for the outcome(s) of ’omics and related technologies.
  • The company should be capable of, and committed to, commercialization of the outcome of the project.
  • The proposal demonstrates that the PBDF represents a unique funding opportunity for the project at this stage.  Although matching funds (cash or in-kind) are required, a 1:1 match is not necessary.
  1. where “’omics” includes genomics, proteomics, transcriptomics, epigenomics, bioinformatics and other related disciplines that involve systematic, comprehensive and high-throughput procedures to study cellular constituents and function

AcCELLerate-ON

by

AcCELLerate-ON, Canada’s first regional cellular agriculture competition, funds four cutting edge cellular agriculture-focused food and beverage projects

With a potential result of food innovations that will create billions in economic value for Canada and environmental benefit for the world, Canadian Food Innovation Network (CFIN) and Ontario Genomics launched AcCELLerate-ON, Canada’s first regional cellular agriculture competition. Designed to spark food innovation, this program will support the research and development of viable food production methods such as cell culture, precision fermentation, tissue engineering, scaffolding and hybridizing production capabilities.

Funded Projects

On May 3, 2022 The Canadian Food Innovation Network (CFIN) and Ontario Genomics have announced the recipients of more than $900K in funding through their AcCELLerate-ON competition. AcCELLerate-ON is Canada’s first regional cellular agriculture competition, supporting the research and development of novel and innovative viable food production methods with the intent to drive economic growth and Ontario’s global leadership in this new and sustainable way to produce food.

The four genomics and engineering biology projects were chosen for their potential to drive food innovation, address industry opportunities, solve challenges, and benefit the cellular agriculture ecosystem and food and beverage industry in Ontario.

Landing Pad Investment Program (LPIP)

by

Driving forward our vision of developing the engineering biology ecosystem within Ontario and Canada, Ontario Genomics is enabling start-ups by providing investment and in-kind support through the Landing Pad Investment Program (LPIP).

The Landing Pad Investment Program aligns well with our strategic goals to advance genomics, applied research, and innovation to drive industry’s competitiveness, by providing access to high-risk investment, fostering connections between businesses, funders, investors and others, and advocating for policies that enable commercialization and implementation of genomics-based technologies. This enables a higher return on investments in genomics technology research, development and commercialization, filling a critical gap in Ontario’s life sciences ecosystem.

Ontario Genomics offers support to start-ups that attend an International Accelerator Program and wish to return to Ontario upon completion. Our official partner IndieBio (San Francisco & New York), backed by the global venture capital firm SOSV., offers $250,000 USD to companies accepted to their program. Successful applicants returning to Ontario from IndieBio or another approved international accelerator program may receive up to $100,000 CAD in investment from Ontario Genomics.

We are also working with Ontario Incubator Partners to provide access to laboratory space and mentorship. The mentorship includes regulatory pathway assistance, global outlook and connections, understanding of export markets, business model strategy, technical development, funding and foreign investment. Our partners are some of Ontario’s leading incubators and support organizations such as Velocity, Synapse, McMaster Innovation Park and Toronto Metropolitan University’s Science Discovery Zone (SDZ).

Ontario Regional Priorities Partnership Program (ON-RP3)

by

The Ontario Regional Priorities Partnership Program (ON-RP3) is supporting Ontario-focused, industry-academic partnership projects that will positively impact Ontario’s agriculture and agri-food sector.

The funding is supporting proof-of-concept stage projects that will deliver genomics/genomics-derived technologies, tools and processes to provide solutions to industry-identified challenges or opportunities within the sector. ON-RP3 will help industry take applied research to the implementation and commercialization stages. These solutions will be implemented by 2024.

Funded Ontario RP3 Projects

2019

On December 5, 2019 Bettina Hamelin, President and CEO of Ontario Genomics, announced the eight successful ON-RP3 project teams. In total, eight projects are being funded across Ontario through a $2M investment by the Agricultural Adaptation Council and Ontario Genomics (through Genome Canada). This investment is leveraging $975,000 in industry contributions, for a total of over $2.95 M to drive genomics-derived technologies, tools and processes to create more jobs and grow the Ontario economy.

Large Scale Applied Research Project (LSARP) Competition

by

The Large-Scale Applied Research Project (LSARP) Competition provides support to large-scale genomics research projects using genomic approaches to address challenges in Canada’s main economic sectors, as well as strategic initiative programs that address national and international opportunities. Launched on May 17, 2010, the funding for this competition is targeted to projects focused on applying genomics research to create socio-economic benefits for Canada, to be realized or initiated before the end of the project

Funded Ontario LSARP Projects

On July 26, 2021 Ontario Genomics announced a total investment of over $39 million into the Large Scale Applied Research Program (LSARP) projects from across Ontario that will help address the impact of climate change and pollution. Genome Canada announced funding for eight Canadian projects under the Genomic Solutions for Natural Resources and the Environment competition with an overall budget of $58.6 million. Five of the eight projects involve Ontario researchers, with over $39 million of the nationwide budget being received by provincial researchers.

On July 23, 2019, The Honourable Kirsty Duncan, Minister of Science and Sport, announced the $29.3 million investment in the 2018 Large-Scale Applied Research Project (LSARP) Competition: Genomics Solutions for Agriculture, Agri-food, Fisheries and Aquaculture. The eight (8) projects approved for funding use genomics to advance the sustainability, productive capacity and competitive position of the Canadian agriculture and agri-food & fisheries and aquaculture sectors, thereby strengtheing Canada’s economy and the wellbeing of Canadians. Ontario Genomics is leading or co-leading (5) research projects bringing $9.8M of federal funding to Ontario which leverages an additional of $17.1M for a total investment of nearly $27M.

On January 23, 2018, Genome Canada, in collaboration with the Canadian Institutes of Health Research, and project cofunding partners, announced an investment of approx. $162 million over four years in 15 new genomics and precision health projects. These projects – spanning multiple disease areas – demonstrate how genomics-based research can contribute to a more evidence-based approach to health and thereby improve health outcomes for patients, as well as enhance the cost-effectiveness of Canada’s health-care system. Four (4) research projects through Ontario Genomics were approved for funding:

On December 8, 2016, Genome Canada announced the $110 million investment in the 2015 LSARP competition. The thirteen projects approved for funding use genomics to address the challenges and opportunities facing Canada’s natural resources and environment sectors to drive sustainability, growth, productivity, commercialization and global competitiveness. Three (3) research projects through Ontario Genomics – with one Genome British Columbia co-lead – were approved for funding:

On July 21, 2015, Genome Canada announced the $93 million investment in the 2014 LSARP competition. The eleven projects approved for funding applied genomics in the agri-food and fisheries/aquaculture sectors to address challenges and opportunities related to global food safety, security and sustainable production. Three (3) research projects received funding through Ontario Genomics:

 

On March 26, 2013, Genome Canada, in partnership with the Canadian Institutes of Health Research, announced the $149.8 million investment in the 2012 LSARP competition. The seventeen projects approved for funding were focused on the application of genomics to tailor patient treatments and therapies in fields as diverse as epilepsy, autism, HIV/AIDS, cancer, cardiovascular disease, rare neurological diseases, and stroke. Four (4) research projects received funding through Ontario Genomics, and one project was co-led with Genome Quebec:

On May 9, 2011, Genome Canada announced the results of the 2010 LSARP competition. Three (3) projects received funding through Ontario Genomics, with a combined total investment of $23.8 million ($11.3 million from Genome Canada, $12.5 million from co-funding):

Receive Email Updates from Ontario Genomics

Are you curious about Ontario Genomics, our funding opportunities, or relevant news? Sign up for updates to stay in the know:

" " indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What’s Happening in Real-Time
Twitter Linkedin-in Instagram Vimeo-v

Copyright © 2023 Ontario Genomics. All Rights Reserved.

Terms & Privacy Policy